The effect of exercise on von Willebrand factor and ADAMTS-13 in individuals with type 1 and type 2B von Willebrand disease

J Thromb Haemost. 2008 Jan;6(1):90-6. doi: 10.1111/j.1538-7836.2007.02790.x. Epub 2007 Oct 8.

Abstract

Background: The effect of exercise on von Willebrand factor (VWF) and ADAMTS-13 levels in individuals with von Willebrand disease (VWD) has never been reported.

Objectives: The aim was to quantify the effect of a standardized exercise protocol on individuals with type 1 and type 2B VWD.

Patients/methods: Thirty individuals from three groups (10 controls, 11 with type 1 VWD and 9 with type 2B VWD) completed the Standard Bruce Protocol Treadmill Test. A bleeding questionnaire was administered and blood tests were performed pre- and immediately postexercise. The groups were well matched for age, gender and body mass index (BMI).

Results: There was a correlation in all groups between the metabolic equivalents (METS) achieved and the degree of change of VWF and FVIII:C levels (P < 0.002, Pearson's correlation). There was a significant postexercise increase in VWF:Ag, VWF:RCo, FVIII:C and activated VWF levels in both the control group and in the type 2B VWD group, but not in the type 1 VWD group. Specific to the type 2B VWD group was an increase in the percentage of high molecular weight multimers (P = 0.022), a decrease in the mean platelet count compared with the other groups (P < 0.001) and an increase in the ADAMTS-13 level (P = 0.001).

Conclusions: There are significant differences in the effects of exercise on individuals with type 1 and type 2B VWD compared with controls. Further clinical studies are necessary to evaluate exercise as a therapeutic option in VWD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ADAM Proteins / blood*
  • ADAMTS13 Protein
  • Case-Control Studies
  • Exercise / physiology*
  • Factor VIII / analysis
  • Humans
  • Platelet Count
  • von Willebrand Diseases / blood*
  • von Willebrand Diseases / classification
  • von Willebrand Diseases / therapy*
  • von Willebrand Factor / analysis*

Substances

  • von Willebrand Factor
  • Factor VIII
  • ADAM Proteins
  • ADAMTS13 Protein
  • ADAMTS13 protein, human